These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 8321867)
1. Vitiligo: where do we stand? Ortonne JP; Bose SK Pigment Cell Res; 1993 Mar; 6(2):61-72. PubMed ID: 8321867 [TBL] [Abstract][Full Text] [Related]
2. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Gauthier Y; Cario Andre M; Taïeb A Pigment Cell Res; 2003 Aug; 16(4):322-32. PubMed ID: 12859615 [TBL] [Abstract][Full Text] [Related]
3. Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth. Yu HS J Biomed Sci; 2002; 9(6 Pt 2):564-73. PubMed ID: 12432222 [TBL] [Abstract][Full Text] [Related]
4. Melanocytes are not absent in lesional skin of long duration vitiligo. Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216 [TBL] [Abstract][Full Text] [Related]
5. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862 [TBL] [Abstract][Full Text] [Related]
6. Review of the etiopathomechanism of vitiligo: a convergence theory. Le Poole IC; Das PK; van den Wijngaard RM; Bos JD; Westerhof W Exp Dermatol; 1993 Aug; 2(4):145-53. PubMed ID: 8162332 [TBL] [Abstract][Full Text] [Related]